Back

The adjusted ferritin inflammation index: a novel metric for mortality risk in heart failure

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Multiparametric insights into heart failure: from molecular pathways to frailty and mortality risk Comorbidities HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Cetin ALAK

Uludag University, Bursa (Turkiye)

5 More presentations in this session

Presentation thumbnail
Decrypting molecular pathways of insulin and glucose metabolism by targeted proteomics in heart failure
Miss N. Belanger (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Multiparametric assessment of frailty in transthyretin amyloidosis cardiomyopathy and its correlation with prognostic staying scores.
Doctor M. Antunez-Ballesteros (Coruna, A, ES)
Abstract Slides Video
Presentation thumbnail
Impact of SGLT-2 inhibitors on anemia in heart failure patients: a systematic review and meta-analysis
Doctor M. Yacoub (Dublin, IE)
Abstract Slides Video
Presentation thumbnail
Malnutrition and risk of one-year mortality in elderly patients with chronic heart failure
Mr C. Jimenez Mendez (Cadiz, ES) Doctor J. Perez Rivera (Burgos, ES)
Abstract Slides Video
Presentation thumbnail
Changes in platelets count as a marker of myocardial iron uptake after ferric carboxymaltose in patients with heart failure
Assistant Professor C. Garcia-Conejo (Malaga, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Multiparametric insights into heart failure: from molecular pathways to frailty and mortality risk

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
High ferritin levels as a potential risk marker for disease severity and prognosis in heart failure
thumbnail
Congress Presentation
New applications of traditional inflammation markers in heart failure prognosis
thumbnail
Congress Presentation
The effect of changes in ferritin levels on NTpro-BNP levels in the presence or absence of anemia in heart failure patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources